Peng Yue is the founder of ReviR Therapeutics. ReviR Therapeutics has raised $55M in total funding. Latest round: Seed.
Peng Yue is the Co-founder and CEO of ReviR Therapeutics, a genomics-based biopharmaceutical company developing oral RNA-targeted genetic medicines for CNS disorders, including ALS. He leads the company's AI-driven drug development strategy focused on rare diseases and immunology.
Full founder directory · Investor directory · Company funding database · Fundraising library